These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2862713)

  • 1. Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms. British Thoracic Society Research Committee.
    Thorax; 1985 May; 40(5):358-63. PubMed ID: 2862713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis.
    Martin AJ; Smalley CA; George RH; Healing DE; Anderson CM
    Arch Dis Child; 1980 Aug; 55(8):604-7. PubMed ID: 7436516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis.
    Penketh AR; Hodson ME; Batten JC
    Br J Dis Chest; 1983 Apr; 77(2):179-84. PubMed ID: 6871085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa.
    Stead RJ; Hodson ME; Batten JC
    Br J Dis Chest; 1987 Jul; 81(3):272-9. PubMed ID: 3311119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
    Hodson ME; Wingfield HJ; Batten JC
    Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
    Penketh A; Hodson ME; Gaya H; Batten JC
    Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.
    Marks MI; Prentice R; Swarson R; Cotton EK; Eickhoff TC
    J Pediatr; 1971 Nov; 79(5):822-8. PubMed ID: 5000612
    [No Abstract]   [Full Text] [Related]  

  • 8. Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis.
    Padoan R; Cambisano W; Costantini D; Crossignani RM; Danza ML; Trezzi G; Giunta A
    Pediatr Infect Dis J; 1987 Jul; 6(7):648-53. PubMed ID: 3302917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
    Permin H; Koch C; Høiby N; Christensen HO; Møller AF; Møller S
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.
    Gold R; Overmeyer A; Knie B; Fleming PC; Levison H
    Pediatr Infect Dis; 1985; 4(2):172-7. PubMed ID: 3885181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?
    Beaudry PH; Marks MI; McDougall D; Desmond K; Rangel R
    J Pediatr; 1980 Jul; 97(1):144-7. PubMed ID: 7381634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gentamicin, carbenicillin and gentamicin, and carbenicillin in Pseudomonas sepsis in monkeys.
    Saslaw S; Carlisle HN; Moheimani M
    Antimicrob Agents Chemother; 1973 Feb; 3(2):274-8. PubMed ID: 4208283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis.
    Hyatt AC; Chipps BE; Kumor KM; Mellits ED; Lietman PS; Rosenstein BJ
    J Pediatr; 1981 Aug; 99(2):307-14. PubMed ID: 7019407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics.
    Vinks AA; Brimicombe RW; Heijerman HG; Bakker W
    J Antimicrob Chemother; 1997 Jul; 40(1):125-33. PubMed ID: 9249216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Padoan R; Brienza A; Crossignani RM; Lodi G; Giunta A; Assael BM; Granata F; Passarella E; Vallaperta PA; Xerri L
    J Pediatr; 1983 Aug; 103(2):320-4. PubMed ID: 6348228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
    Huang NN; Palmer J; Keith H; Schidlow D; Braverman S; Goldberg M
    J Antimicrob Chemother; 1983 May; 11 Suppl B():205-14. PubMed ID: 6352603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
    Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patients.
    Ramphal R; Kramer BS; Rand KH; Weiner RS; Shands JW
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():81-8. PubMed ID: 6352659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobramycin in treatment of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
    Crozier DN; Khan SR
    J Infect Dis; 1976 Aug; 134 Suppl():S187-90. PubMed ID: 823275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized double-blind evaluation of ceftazidime dose ranging in hospitalized patients with cystic fibrosis.
    Reed MD; Stern RC; O'Brien CA; Crenshaw DA; Blumer JL
    Antimicrob Agents Chemother; 1987 May; 31(5):698-702. PubMed ID: 3111360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.